Professional product catalogue

Neurology medicines

Neurology medicines concern different nervous system functions: neuronal excitability in epilepsy, dopaminergic transmission in Parkinson's disease and mechanisms specific to migraine. These fields involve neither one active substance nor a uniform pharmaceutical form. Their families combine varied mechanisms and delivery profiles. Understanding neurotransmitters, ion channels and specific targets helps place the medicines beyond the name of a neurological condition alone. Motor, sensory and other manifestations provide context without turning a broad disease label into a treatment selection or equivalence rule.

Epilepsy medicines

Epilepsy medicines influence neuronal excitability and nerve-signal transmission through varied mechanisms. They differ in substances, indications and pharmaceutical forms. Epilepsy itself includes several seizure types and syndromes rather than one uniform convulsive manifestation. This category explains antiepileptic families, formulation differences and the terminology associated with these medicines in neurology. Electrical activity, inhibitory and excitatory signalling, and the properties of each preparation provide a more precise context than a single broad description of a medicine against seizures or convulsions.

331 classified products

Parkinson’s disease medicines

Parkinson's disease medicines concern dopaminergic transmission and the motor manifestations associated with this neurological condition. Levodopa, dopamine agonists and other agents have different mechanisms. Oral, transdermal and specialised administration forms retain their own pharmaceutical characteristics. This category explains those families and formulations, distinguishing action on disease manifestations from modification of the neurodegenerative process. It also avoids reducing every symptom to a single mechanism, since Parkinson's disease includes both motor and non-motor features within its wider clinical and neurological setting.

160 classified products

Migraine medicines

Migraine-specific medicines include treatments for an attack and agents used within a preventive approach. Triptans and medicines targeting the CGRP pathway illustrate different mechanisms. Migraine is not simply another name for every headache: it has a neurological setting and characteristic manifestations. This category presents antimigraine families and pharmaceutical forms, distinguishing their roles from general analgesics and other medicines sometimes used within the same care pathway. The timing of a medicine's purpose is meaningful without implying a simple hierarchy of strength.

166 classified products